Heliövaara M, Aho K, Knekt P, Aromaa A, Maatela J, Reunanen A
Social Insurance Institution, Helsinki, Finland.
Ann Rheum Dis. 1995 Oct;54(10):811-4. doi: 10.1136/ard.54.10.811.
To investigate chronic arthritis and rheumatoid factor (RF) for their prediction of premature total and cardiovascular mortality.
In 1978-80, a representative population sample of 8000 Finns aged 30 or more was invited to participate in a comprehensive health examination; 90% complied. Arthritis was diagnosed on the basis of medical history, symptoms, and physical examination. Serum RF was determined by the sensitised sheep cell agglutination test.
By the end of 1992 1597 of the subjects had died from all causes, including 876 deaths from cardiovascular diseases. When adjusted for age, gender and smoking, the relative risk of persons with RF positive arthritis dying from any cause was 1.61 (95% confidence interval (CI) 1.03 to 2.51); RF negative non-erosive arthritis was not associated with mortality (relative risk 1.03; 95% CI 0.72 to 1.49). In the absence of arthritis, 'false positive' RF titres > or = 128 predicted cardiovascular deaths with a relative risk of 1.74 (95% CI 1.06 to 2.86).
Both RF positive arthritis and false positive RF reactions predict mortality, but through different disease patterns.
研究慢性关节炎和类风湿因子(RF)对过早出现的全因死亡率和心血管死亡率的预测作用。
1978年至1980年,邀请了8000名年龄在30岁及以上具有代表性的芬兰人群样本参加全面的健康检查;90%的人依从参加。根据病史、症状和体格检查诊断关节炎。通过致敏羊细胞凝集试验测定血清RF。
到1992年底,1597名受试者已死于各种原因,其中876人死于心血管疾病。在对年龄、性别和吸烟情况进行校正后,RF阳性关节炎患者因任何原因死亡的相对风险为1.61(95%置信区间(CI)为1.03至2.51);RF阴性的非侵蚀性关节炎与死亡率无关(相对风险为1.03;95%CI为0.72至1.49)。在无关节炎的情况下,“假阳性”RF滴度≥128预测心血管死亡的相对风险为1.74(95%CI为1.06至2.86)。
RF阳性关节炎和RF假阳性反应均能预测死亡率,但通过不同的疾病模式。